Association between lipoprotein-associated phospholipase A2 activity and coronary heart disease

LI Shan-shan,JIA Mei,YIN Yue
2012-01-01
Abstract:Objective To explore the correlation the activity of lipoprotein-associated phospholipase A2(Lp-PLA2) in patients with coronary heart diseases(CHD),investigate whether Lp-PLA2 is a risk factor of CHD.Methods Test and investigate 239 people with coronary heart disease treated with lipid-lowering drug(LLD),154 people with coronary heart disease untreated with LLD and 378 healthy controls of various biochemical index and clinical basic information,respectively.At the same time,our study use immunoturbidimetry(Cayman's PAF Acetylhydrolase Assay Kit) to test the activity of Lp-PLA2.Results CHD groups whether were treated LLD had significantly higher Lp-PLA2 activitiy than the controls(35.01(15.96,53.32)nmol/ml/min,28.74(16.72,53.58)nmol/ml/min,22.67(15.55,28.62)nmol/ml/min,P<0.001),respectively);After additional adjustment for various traditional cardiovascular risk factors,including ages,sex,CHO,TG,Hs-CRP,Lp(a),and GLU.,the highest quartile of Lp-PLA2 activity comparison to the bottom quartile,the OR was 3.15(95%CI:1.05-9.50) for CHD.Conclusion Lp-PLA2 activitiy was significantly higher in CHD group and was a risk factor for CHD.
What problem does this paper attempt to address?